These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 30948822

  • 1. Optimal blood pressure targets for patients with hypertension: a systematic review and meta-analysis.
    Sakima A, Satonaka H, Nishida N, Yatsu K, Arima H.
    Hypertens Res; 2019 Apr; 42(4):483-495. PubMed ID: 30948822
    [Abstract] [Full Text] [Related]

  • 2. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A.
    Lancet; 2016 Jan 30; 387(10017):435-43. PubMed ID: 26559744
    [Abstract] [Full Text] [Related]

  • 3. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Bangalore S, Toklu B, Gianos E, Schwartzbard A, Weintraub H, Ogedegbe G, Messerli FH.
    Am J Med; 2017 Jun 30; 130(6):707-719.e8. PubMed ID: 28109971
    [Abstract] [Full Text] [Related]

  • 4. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
    Wang J, Chen Y, Xu W, Lu N, Cao J, Yu S.
    PLoS One; 2019 Jun 30; 14(4):e0215362. PubMed ID: 30978254
    [Abstract] [Full Text] [Related]

  • 5. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
    Brunström M, Carlberg B.
    JAMA Intern Med; 2018 Jan 01; 178(1):28-36. PubMed ID: 29131895
    [Abstract] [Full Text] [Related]

  • 6. More Versus Less Blood Pressure Lowering: An Update.
    Atkins ER, Rodgers A.
    Clin Ther; 2016 Oct 01; 38(10):2135-2141. PubMed ID: 27633256
    [Abstract] [Full Text] [Related]

  • 7. Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): A multicenter open-label randomized controlled trial.
    Liu J, Wang B, Li Y, Yan X, Ge J, Li J.
    Am Heart J; 2023 Mar 01; 257():93-102. PubMed ID: 36493840
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
    Bangalore S, Kumar S, Volodarskiy A, Messerli FH.
    Heart; 2013 May 01; 99(9):601-13. PubMed ID: 22914531
    [Abstract] [Full Text] [Related]

  • 10. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
    Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, Wang H, MacMahon S, Turnbull F, Hillis G, Chalmers J, Perkovic V.
    PLoS Med; 2012 May 01; 9(8):e1001293. PubMed ID: 22927798
    [Abstract] [Full Text] [Related]

  • 11. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A, Thomopoulos C, Parati G.
    Circ Res; 2015 Mar 13; 116(6):1058-73. PubMed ID: 25767290
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K.
    Lancet; 2016 Mar 05; 387(10022):957-967. PubMed ID: 26724178
    [Abstract] [Full Text] [Related]

  • 13. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2016 Apr 05; 34(4):613-22. PubMed ID: 26848994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J, Bruzelius E, Doupe P, Le M, Faghmous J, Baum A.
    JAMA Netw Open; 2019 Mar 01; 2(3):e190005. PubMed ID: 30848803
    [Abstract] [Full Text] [Related]

  • 17. Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA).
    Yano Y, Briasoulis A, Bakris GL, Hoshide S, Wang JG, Shimada K, Kario K.
    J Am Soc Hypertens; 2014 Feb 01; 8(2):103-16. PubMed ID: 24157055
    [Abstract] [Full Text] [Related]

  • 18. More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis.
    Verdecchia P, Angeli F, Gentile G, Reboldi G.
    Hypertension; 2016 Sep 01; 68(3):642-53. PubMed ID: 27456518
    [Abstract] [Full Text] [Related]

  • 19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.